Bio-Rad Laboratories Q2 FY24: revenue $638.5M; diluted EPS −$76.26

Key figures from this report

These are the numbers Bio-Rad Laboratories reported for Q2 FY24, the quarter ended Jun 30, 2024, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

1. Revenue$638.5MNo year-earlier figure tagged10-Q income statement, on EDGAR
2. Net income−$2.2BNo year-earlier figure tagged10-Q income statement, on EDGAR
3. Diluted EPS−$76.26No year-earlier figure tagged10-Q income statement, on EDGAR
4. Cash and cash equivalents$406.9MNo year-earlier figure taggedCash and equivalents only; the company page adds short-term investments.10-Q balance sheet, on EDGAR
5. Cash from operations$97.6MNo year-earlier figure tagged10-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters

Every quarter in the financial tables